Numerous studies have demonstrated that metformin can significantly reduce the risk of cancer in diabetic patients because metformin can induce energy stress by inhibiting the mitochondrial respiratory chain complex I [115, 116], which leads to the increase of AMP/ATP ratio and activation of AMPK [31, 32]. This evidence concerns the gene PRKAB1 and cancer.